6-33287142-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005452.6(WDR46):c.964G>A(p.Val322Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00062 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00032 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00065 ( 0 hom. )
Consequence
WDR46
NM_005452.6 missense
NM_005452.6 missense
Scores
6
13
Clinical Significance
Conservation
PhyloP100: 4.20
Genes affected
WDR46 (HGNC:13923): (WD repeat domain 46) Enables RNA binding activity. Predicted to be involved in maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA). Predicted to be located in nucleoplasm. Predicted to be part of small-subunit processome. Predicted to be active in nucleolus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03643754).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR46 | NM_005452.6 | c.964G>A | p.Val322Ile | missense_variant | 9/15 | ENST00000374617.9 | NP_005443.3 | |
WDR46 | NM_001164267.2 | c.802G>A | p.Val268Ile | missense_variant | 9/15 | NP_001157739.1 | ||
WDR46 | XM_047419523.1 | c.964G>A | p.Val322Ile | missense_variant | 9/14 | XP_047275479.1 | ||
WDR46 | XM_047419524.1 | c.964G>A | p.Val322Ile | missense_variant | 9/11 | XP_047275480.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR46 | ENST00000374617.9 | c.964G>A | p.Val322Ile | missense_variant | 9/15 | 1 | NM_005452.6 | ENSP00000363746.4 | ||
WDR46 | ENST00000444176.1 | c.745G>A | p.Val249Ile | missense_variant | 8/10 | 5 | ENSP00000405568.1 | |||
WDR46 | ENST00000489905.1 | n.160G>A | non_coding_transcript_exon_variant | 2/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000316 AC: 48AN: 151998Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
48
AN:
151998
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000501 AC: 126AN: 251458Hom.: 0 AF XY: 0.000552 AC XY: 75AN XY: 135904
GnomAD3 exomes
AF:
AC:
126
AN:
251458
Hom.:
AF XY:
AC XY:
75
AN XY:
135904
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000651 AC: 952AN: 1461892Hom.: 0 Cov.: 33 AF XY: 0.000685 AC XY: 498AN XY: 727246
GnomAD4 exome
AF:
AC:
952
AN:
1461892
Hom.:
Cov.:
33
AF XY:
AC XY:
498
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000316 AC: 48AN: 152116Hom.: 0 Cov.: 31 AF XY: 0.000336 AC XY: 25AN XY: 74372
GnomAD4 genome
AF:
AC:
48
AN:
152116
Hom.:
Cov.:
31
AF XY:
AC XY:
25
AN XY:
74372
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
4
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
64
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.964G>A (p.V322I) alteration is located in exon 9 (coding exon 9) of the WDR46 gene. This alteration results from a G to A substitution at nucleotide position 964, causing the valine (V) at amino acid position 322 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;.
Polyphen
D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at